Cargando…
3K3A-Activated Protein C Inhibits Choroidal Neovascularization Growth and Leakage and Reduces NLRP3 Inflammasome, IL-1β, and Inflammatory Cell Accumulation in the Retina
3K3A-Activated Protein C (APC) is a recombinant variant of the physiological anticoagulant APC with cytoprotective properties and reduced bleeding risks. We studied the potential use of 3K3A-APC as a multi-target therapeutic option for choroidal neovascularization (CNV), a common cause of vision los...
Autores principales: | Weinberger, Yehonatan, Budnik, Ivan, Nisgav, Yael, Palevski, Dahlia, Ben-David, Gil, Fernández, José A., Margalit, Shany Nivinsky, Levy-Mendelovich, Sarina, Kenet, Gili, Weinberger, Dov, Griffin, John H., Livnat, Tami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341424/ https://www.ncbi.nlm.nih.gov/pubmed/37445820 http://dx.doi.org/10.3390/ijms241310642 |
Ejemplares similares
-
Activated Protein C (APC) and 3K3A-APC-Induced Regression of Choroidal Neovascularization (CNV) Is Accompanied by Vascular Endothelial Growth Factor (VEGF) Reduction
por: Livnat, Tami, et al.
Publicado: (2021) -
3K3A-Activated Protein C Prevents Microglia Activation, Inhibits NLRP3 Inflammasome and Limits Ocular Inflammation
por: Palevski, Dahlia, et al.
Publicado: (2022) -
Possible involvement of NETosis in inflammatory processes in the eye: Evidence from a small cohort of patients
por: Barliya, Tilda, et al.
Publicado: (2017) -
The Histone Deacetylase Inhibitor AN7, Attenuates Choroidal Neovascularization in a Mouse Model
por: Dahbash, Mor, et al.
Publicado: (2019) -
Real-World Data on Bleeding Patterns of Hemophilia A Patients Treated with Emicizumab
por: Levy-Mendelovich, Sarina, et al.
Publicado: (2021)